{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T05:38:21Z","timestamp":1649137101787},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1995,3,1]],"date-time":"1995-03-01T00:00:00Z","timestamp":794016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporosis Int"],"published-print":{"date-parts":[[1995,3]]},"DOI":"10.1007\/bf01623309","type":"journal-article","created":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T05:19:14Z","timestamp":1114924754000},"page":"93-96","source":"Crossref","is-referenced-by-count":4,"title":["Uninterrupted oral bisphosphonate (pamidronate) therapy of patients with osteoporosis is not associated with chronic stimulation of parathyroid hormone secretion"],"prefix":"10.1007","volume":"5","author":[{"given":"J. O.","family":"Landman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. E.","family":"Papapoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"574","volume":"78","author":"J Jowsey","year":"1971","unstructured":"Jowsey J, Riggs B, Kelly PJ, Hossman DL, Bordier P. The treatment of osteoporosis with disodium ethane-1-hydroxy-1, 1-diphosphonate. J Lab Clin Med 1971;78:574\u201384.","journal-title":"J Lab Clin Med"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/cpt1976205593","volume":"20","author":"RP Heaney","year":"1976","unstructured":"Heaney RP, Saville PD. Etidronate disodium in postmenopausal osteoporosis. Clin Pharmacol Ther 1976;20:593\u2013604.","journal-title":"Clin Pharmacol Ther"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0169-6009(89)90095-0","volume":"5","author":"R Valkema","year":"1989","unstructured":"Valkema R, Vismans FJFE, Papapoulos SE, Pauwels EKJ, Bijvoet OLM. Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD. Bone Miner 1989;5:183\u201392.","journal-title":"Bone Miner"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM199005033221803","volume":"322","author":"T Storm","year":"1990","unstructured":"Storm T, Thamsborg G, Steiniche T, Genant HK, Sorensen OH. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990;322:1265\u201371.","journal-title":"N Engl J Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0002-9343(93)90350-X","volume":"95","author":"ST Harris","year":"1993","unstructured":"Harris ST, Watts NB, Jackson RD, et al. Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. Am J Med 1993;95:557\u201367.","journal-title":"Am J Med"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1007\/BF01623004","volume":"Suppl 3","author":"S Adami","year":"1993","unstructured":"Adami S, Baroni MC, Broggini M, et al. Treatment of postmenopausal osteoporosis with continuous daily oral alendronate in comparison with either placebo or intranasal salmon calcitonin. Osteoporosis Int 1993;Suppl 3:S21\u20137.","journal-title":"Osteoporosis Int"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJM199208273270908","volume":"327","author":"BL Riggs","year":"1992","unstructured":"Riggs BL, Melton LJ. The prevention and treatment of osteoporosis. N Engl J Med 1992;327:620\u20137.","journal-title":"N Engl J Med"},{"key":"CR8","first-page":"69","volume":"1","author":"SE Papapoulos","year":"1986","unstructured":"Papapoulos SE, Harinck HIJ, Bijvoet OLM, Gleed JH, Fraher LJ, O'Riordan JLH. Effects of decreasing serum calcium on circulating parathyroid hormone and vitamin D metabolites in normocalcaemic and hypercalcaemic patients treated with APD. Bone Miner 1986;1:69\u201378.","journal-title":"Bone Miner"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/bmj.280.6228.1340","volume":"280","author":"J Reeve","year":"1980","unstructured":"Reeve J. Meunier PJ, Parsons JA, et al. Anabolic effect of human PTH on trabecular bone in involutional osteoporosis: a multicenter trial. BMJ 1980;280:1340\u20134.","journal-title":"BMJ"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1007\/BF01621906","volume":"Suppl 1","author":"J Reeve","year":"1993","unstructured":"Reeve J, Arlot ME, Bradbeer JN, et al. Human parathyroid peptide treatment of vertebral osteoporosis. Osteoporosis Int 1993;Suppl 1:S199\u2013203.","journal-title":"Osteoporosis Int"},{"key":"CR11","first-page":"829","volume-title":"Osteoporosis 1987","author":"RM Neer","year":"1987","unstructured":"Neer RM, Slovik DM, Doppelt S, et al. The use of parathyroid hormone plus 1,25-dihydroxyvitamin D to increase trabecular bone in osteoporotic men and post-menopausal women. In: Christiansen C, Johansen JC, Riis BJ, editors. Osteoporosis 1987. Copenhagen: Osteopress, 1987:829\u201335."},{"key":"CR12","first-page":"64","volume":"27","author":"M Frohlich","year":"1990","unstructured":"Frohlich M, Walsma ST, Paulson C, Papapoulos SE. Immuno-radiometric assay for intact parathyroid hormone: characteristics, clinical application and comparison with a radioimmunoassay. Ann Clin Biochem 1990;27:64\u201372.","journal-title":"Ann Clin Biochem"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0003-2697(60)90050-6","volume":"1","author":"DJ Prockop","year":"1960","unstructured":"Prockop DJ, Udenfriend S. A specific method for the analysis of hydroxyproline in tissues and urine. Anal Biochem 1960;1:228\u201339.","journal-title":"Anal Biochem"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/jbmr.5650050510","volume":"5","author":"DP O'Doherty","year":"1990","unstructured":"O'Doherty DP, Bickerstaff DR, McCloskey EV, et al. Treatment of Paget's disease of bone with aminohydroxybutylidene bisphosphonate. J Bone Miner Res 1990;5:483\u201391.","journal-title":"J Bone Miner Res"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jbmr.5650020403","volume":"2","author":"RM Atkins","year":"1987","unstructured":"Atkins RM, Yates AJP, Gray RES, et al. Aminohexane diphos-phonate in the treatment of Paget's disease. J Bone Miner Res 1987;2:273\u20139.","journal-title":"J Bone Miner Res"},{"key":"CR16","first-page":"690","volume":"6","author":"DW Dempster","year":"1993","unstructured":"Dempster DW, Cosman F, Parisien M, Shen V, Linday R. Anabolic actions of parathyroid hormone on bone. Endocr Rev 1993;6:690\u2013709.","journal-title":"Endocr Rev"},{"key":"CR17","first-page":"S87","volume":"12","author":"SE Papapoulos","year":"1991","unstructured":"Papapoulos SE, Landman JO, Bijvoet OLM, et al. The use of bisphosphonates in the treatment of osteoporosis. Bone 1991;12:S87\u201395.","journal-title":"Bone"},{"key":"CR18","first-page":"331","volume-title":"Osteoporosis: physiological basis, assessment and treatment","author":"OLM Bijvoet","year":"1990","unstructured":"Bijvoet OLM, Valkema R, Lowik CWGM, Papapoulos SE. The use of bisphosphonates in osteoporosis. In: De Luca HF, Mazess R, editors. Osteoporosis: physiological basis, assessment and treatment. New York: Elsevier Science, 1990:331\u20138."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/jbmr.5650061110","volume":"6","author":"G Pluijm van der","year":"1991","unstructured":"van der Pluijm G, L\u00f6wik CWGM, de Groot H, et al. Modulation of PTH-stimulated osteoclastic resorption by bisphosphonates in fetal mouse bone explants. J Bone Miner Res 1991;6:1203\u201310.","journal-title":"J Bone Miner Res"},{"key":"CR20","unstructured":"van der Pluijm G, van Beek E, L\u00f6wik C, Papapoulos S. Involvement of Il-6 in modulation of osteoclastic resorption of bisphosphonates. J Bone Miner Res 1990; (Suppl 2): S234."},{"key":"CR21","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1172\/JCI116422","volume":"91","author":"M Sahni","year":"1993","unstructured":"Sahni M, Guenther H, Fleisch H, Collin P, Martin TJ. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest 1993;91:2004\u201311.","journal-title":"J Clin Invest"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/8756-3282(92)90205-B","volume":"13","author":"HC Tenenbaum","year":"1992","unstructured":"Tenenbaum HC, Torontali M, Sukhu B. Effects of bisphosphonates and inorganic pyrophosphate on osteogenesis in vitro. Bone 1992;13:249\u201355.","journal-title":"Bone"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1172\/JCI116872","volume":"92","author":"R Balena","year":"1993","unstructured":"Balena R, Toolan BC, Shea M, et al. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovar-iectomized nonhuman primates. J Clin Invest 1993;92:2577\u201386.","journal-title":"J Clin Invest"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01623309.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01623309\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01623309","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T18:30:49Z","timestamp":1557253849000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01623309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["BF01623309"],"URL":"https:\/\/doi.org\/10.1007\/bf01623309","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,3]]}}}